15 Stocks Moving in Tuesday's Pre-Market Session

Gainers

• Xeris Pharmaceuticals, Inc. XERS shares rose 21.6% to $7.04 in pre-market trading after the company announced positive topline results from the in-clinic stage of a Phase 2 study of its ready-to-use glucagon.
• Hepion Pharmaceuticals, Inc. HEPA shares rose 17.7% to $6.18 in pre-market trading after the company highlighted a publication that discussed Cyclophilin inhibition as a potential treatment for NASH.
• BioNTech SE BNTX shares rose 7.9% to $48.10 in pre-market trading after gaining 11.31% on Monday.
• Himax Technologies, Inc. HIMX shares rose 7.7% to $3.50 in pre-market trading after the company issued Q4 sales guidance above analyst estimates.
• Dorian LPG Ltd. LPG rose 7.2% to $16.49 in pre-market trading. Dorian LPG will replace SRC Energy effective prior to the open of trading on January 15.
• PBF Energy Inc PBF rose 5.4% to $32.13 in pre-market trading. Bank of America upgraded PBF Energy from Neutral to Buy.
• Stealth BioTherapeutics Corp MITO shares rose 5.3% to $3.17 in pre-market trading.
• Acorda Therapeutics, Inc. ACOR rose 4.8% to $2.60 in pre-market trading.
• Microchip Technology Incorporated MCHP rose 4.8% to $108.69 in pre-market trading after the company narrowed preliminary Q3 sales guidance from $1.244 billion-$1.298 billion to $1.281 billion-$1.288 billion vs the $1.24 billion estimate.
• Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• CTI Industries Corporation CTIB fell 19.2% to $2.10 in pre-market trading after surging 225.00% on Monday.
• Antares Pharma, Inc. ATRS shares fell 7% to $3.98 in pre-market trading.
• Cassava Sciences, Inc. SAVA fell 7% to $8.02 in pre-market trading after dropping 10.57% on Monday.
• MAG Silver Corp. MAG fell 5.4% to $10.70 in pre-market trading.
• Alexandria Real Estate Equities Inc ARE fell 3.4% to $155.60 in pre-market trading after reporting a 6 million share common stock offering.
• Intra-Cellular Therapies Inc ITCI shares fell 2.8% to $29.78 in pre-market trading after the company reported a proposed public offering of 10,000,000 shares of common stock.